Guideline: Screening for prostate cancer (Republic of Cyprus)

From Beacon
Revision as of 11:22, 6 December 2025 by Lucas (talk | contribs) (Update categories.)

forproviders forpolicymakers republicofcypruscountry Go back to Republic of Cyprus page

Primary purpose: To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer.

Sponsor, manager or home institution: Ministry of Health and Health Insurance Organization.

Type of information: This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. diagnosis, medical procedures, age, screening, check-up examinations.

Cancer Areas of Interest: C60-C63: Male genitalia cancer. Click here to learn more.

Access to information: Click here to access.

Prostate Testicles Penis dataOwner::Ministry of Health dataOwner::Health Insurance Organization availableVariable::diagnosis availableVariable::medical procedures availableVariable::age availableVariable::screening availableVariable::check-up examinations hasCancerType::C60-C63: Male genitalia cancer isPracticeGuideline hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types